ITRM ITERUM THERAPEUTICS PLC Delisting Actions 8-K Filing 2024 - Nasdaq Compliance Iterum Therapeutics plc has regained compliance with Nasdaq listing requirements, cancelling a scheduled hearing, and will continue to be traded on the Nasdaq Capital Market.Get access to all SEC 8-K filings of the ITERUM THERAPEUTICS PLC